Alpheus Medical

formerly Alpheus

Alpheus Medical is a biotech company in Chanhassen, United States, founded in 2014. It has raised $84.0M across 4 rounds, most recently a $52.0M Series B in May 2025.

Developing a New Drug-Ultrasound Therapy for Glioblastoma

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$84.0M
Last Round
$52.0M Series BMay 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

Alpheus Medical is a private, clinical-stage biotechnology company headquartered in Chanhassen, Minnesota, developing Porphyrin Metabolite Activation (PoMA), a drug-led, tumor-selective oncology approach for the treatment of glioblastoma. The company's therapy is designed to activate 5-ALA-derived protoporphyrin IX (PpIX) localized within tumor tissue using proprietary low-intensity defocused ultrasound, enabling targeted pharmacologic activity without systemic side effects. Founded by Dr. Vijay Agarwal, Alpheus's lead program is currently being evaluated in a randomized Phase 2b clinical trial for newly diagnosed glioblastoma patients who continue standard-of-care treatment alongside the investigational therapy. In May 2025, Alpheus closed a $52 million Series B funding round to support the expanded clinical trial. The company's scientific advisory board includes leading neuro-oncologists from Northwestern University, Harvard Medical School, and Dana-Farber Cancer Institute.

Summary

It lists 11–50 employees. It has raised $84.0M in total across 4 rounds, most recently a $52.0M Series B round in May 2025. Investors include OrbiMed, Action Potential Venture Capital and HealthQuest Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BMay 2025
$52.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alpheus Medical on Indexed.vc
<a href="https://indexed.vc/companies/alpheus-medical"><img src="https://indexed.vc/api/badge/company/alpheus-medical" alt="Alpheus Medical on Indexed.vc" width="260" height="76" /></a>